Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515242 · ClinicalTrials.gov registry record · Phase 1
Therapeutic Massage for Generalized Anxiety Disorder
A Phase 1 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 1
- Development phase
- 68
- Enrollment target
NCT00515242: Completed Phase 1 study, sponsored by Kaiser Permanente.
NCT00515242 is a Phase 1 study that has completed, run by Kaiser Permanente. The registered enrollment target is 68 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00515242, a Phase 1 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the relative effectiveness of three relaxation treatments (therapeutic massage, thermotherapy, and time in a relaxing environment) in reducing anxiety in persons with Generalized Anxiety Disorder.
Interventions
- BEHAVIORAL massage
- BEHAVIORAL thermotherapy
- BEHAVIORAL relaxing environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
What the finished NCT00515242 record still lists
NCT00515242 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 3 interventions - of which massage is the first listed.
NCT00515242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00515242 about?
NCT00515242 is a clinical study titled "Therapeutic Massage for Generalized Anxiety Disorder". The purpose of this study is to compare the relative effectiveness of three relaxation treatments (therapeutic massage, thermotherapy, and time in a relaxing environment) in reducing anxiety in persons with Generalized Anxiety Disorder.
What is the current status of trial NCT00515242?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2007-09. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00515242?
The interventions under investigation include: massage (BEHAVIORAL), thermotherapy (BEHAVIORAL), relaxing environment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00515242?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00515242's enrollment target sits among peer trials
68 776th of 2000 higher than 1,219 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia